Global Vaccines Administered Orally Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccines Administered Orally Consumption 2016-2026

2.1.2 Vaccines Administered Orally Consumption CAGR by Region

2.2 Vaccines Administered Orally Segment by Type

2.2.1 Human

2.2.2 Animal

2.3 Vaccines Administered Orally Sales by Type

2.3.1 Global Vaccines Administered Orally Sales Market Share by Type (2016-2021)

2.3.2 Global Vaccines Administered Orally Revenue and Market Share by Type (2016-2021)

2.3.3 Global Vaccines Administered Orally Sale Price by Type (2016-2021)

2.4 Vaccines Administered Orally Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Vaccines Administered Orally Sales by Application

2.5.1 Global Vaccines Administered Orally Sale Market Share by Application (2016-2021)

2.5.2 Global Vaccines Administered Orally Revenue and Market Share by Application (2016-2021)

2.5.3 Global Vaccines Administered Orally Sale Price by Application (2016-2021)

3 Global Vaccines Administered Orally by Company

3.1 Global Vaccines Administered Orally Sales Market Share by Company

3.1.1 Global Vaccines Administered Orally Sales by Company (2019-2021)

3.1.2 Global Vaccines Administered Orally Sales Market Share by Company (2019-2021)

3.2 Global Vaccines Administered Orally Revenue Market Share by Company

3.2.1 Global Vaccines Administered Orally Revenue by Company (2019-2021)

3.2.2 Global Vaccines Administered Orally Revenue Market Share by Company (2019-2021)

3.3 Global Vaccines Administered Orally Sale Price by Company

3.4 Global Manufacturers Vaccines Administered Orally Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccines Administered Orally Product Location Distribution

3.4.2 Players Vaccines Administered Orally Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Vaccines Administered Orally by Region

4.1 Global Vaccines Administered Orally by Region

4.1.1 Global Vaccines Administered Orally Sales by Region

4.1.2 Global Vaccines Administered Orally Revenue by Region

4.2 Americas Vaccines Administered Orally Sales Growth

4.3 APAC Vaccines Administered Orally Sales Growth

4.4 Europe Vaccines Administered Orally Sales Growth

4.5 Middle East & Africa Vaccines Administered Orally Sales Growth

5 Americas

5.1 Americas Vaccines Administered Orally Sales by Country

5.1.1 Americas Vaccines Administered Orally Sales by Country (2016-2021)

5.1.2 Americas Vaccines Administered Orally Revenue by Country (2016-2021)

5.2 Americas Vaccines Administered Orally Sales by Type

5.3 Americas Vaccines Administered Orally Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccines Administered Orally Sales by Region

6.1.1 APAC Vaccines Administered Orally Sales by Region (2016-2021)

6.1.2 APAC Vaccines Administered Orally Revenue by Region (2016-2021)

6.2 APAC Vaccines Administered Orally Sales by Type

6.3 APAC Vaccines Administered Orally Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Vaccines Administered Orally by Country

7.1.1 Europe Vaccines Administered Orally Sales by Country (2016-2021)

7.1.2 Europe Vaccines Administered Orally Revenue by Country (2016-2021)

7.2 Europe Vaccines Administered Orally Sales by Type

7.3 Europe Vaccines Administered Orally Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccines Administered Orally by Country

8.1.1 Middle East & Africa Vaccines Administered Orally Sales by Country (2016-2021)

8.1.2 Middle East & Africa Vaccines Administered Orally Revenue by Country (2016-2021)

8.2 Middle East & Africa Vaccines Administered Orally Sales by Type

8.3 Middle East & Africa Vaccines Administered Orally Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Vaccines Administered Orally Distributors

10.3 Vaccines Administered Orally Customer

11 Global Vaccines Administered Orally Market Forecast

11.1 Global Vaccines Administered Orally Forecast by Region

11.1.1 Global Vaccines Administered Orally Forecast by Regions (2021-2026)

11.2.2 Global Vaccines Administered Orally Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Vaccines Administered Orally Forecast by Type

11.7 Global Vaccines Administered Orally Forecast by Application

12 Key Players Analysis

12.1 Merck

12.1.1 Merck Company Information

12.1.2 Merck Vaccines Administered Orally Product Offered

12.1.3 Merck Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Merck Main Business Overview

12.1.5 Merck Latest Developments

12.2 GSK

12.2.1 GSK Company Information

12.2.2 GSK Vaccines Administered Orally Product Offered

12.2.3 GSK Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 GSK Main Business Overview

12.2.5 GSK Latest Developments

12.3 Sanofi

12.3.1 Sanofi Company Information

12.3.2 Sanofi Vaccines Administered Orally Product Offered

12.3.3 Sanofi Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Sanofi Main Business Overview

12.3.5 Sanofi Latest Developments

12.4 Lanzhou Institute

12.4.1 Lanzhou Institute Company Information

12.4.2 Lanzhou Institute Vaccines Administered Orally Product Offered

12.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Lanzhou Institute Main Business Overview

12.4.5 Lanzhou Institute Latest Developments

12.5 Serum Institute

12.5.1 Serum Institute Company Information

12.5.2 Serum Institute Vaccines Administered Orally Product Offered

12.5.3 Serum Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Serum Institute Main Business Overview

12.5.5 Serum Institute Latest Developments

12.6 Valneva

12.6.1 Valneva Company Information

12.6.2 Valneva Vaccines Administered Orally Product Offered

12.6.3 Valneva Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Valneva Main Business Overview

12.6.5 Valneva Latest Developments

12.7 Shanghai United Cell

12.7.1 Shanghai United Cell Company Information

12.7.2 Shanghai United Cell Vaccines Administered Orally Product Offered

12.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Shanghai United Cell Main Business Overview

12.7.5 Shanghai United Cell Latest Developments

12.8 Bibcol

12.8.1 Bibcol Company Information

12.8.2 Bibcol Vaccines Administered Orally Product Offered

12.8.3 Bibcol Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Bibcol Main Business Overview

12.8.5 Bibcol Latest Developments

12.9 PaxVax

12.9.1 PaxVax Company Information

12.9.2 PaxVax Vaccines Administered Orally Product Offered

12.9.3 PaxVax Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 PaxVax Main Business Overview

12.9.5 PaxVax Latest Developments

12.10 Vabiotech

12.10.1 Vabiotech Company Information

12.10.2 Vabiotech Vaccines Administered Orally Product Offered

12.10.3 Vabiotech Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Vabiotech Main Business Overview

12.10.5 Vabiotech Latest Developments

12.11 Tiantan Biological

12.11.1 Tiantan Biological Company Information

12.11.2 Tiantan Biological Vaccines Administered Orally Product Offered

12.11.3 Tiantan Biological Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Tiantan Biological Main Business Overview

12.11.5 Tiantan Biological Latest Developments

12.12 EuBiologics

12.12.1 EuBiologics Company Information

12.12.2 EuBiologics Vaccines Administered Orally Product Offered

12.12.3 EuBiologics Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 EuBiologics Main Business Overview

12.12.5 EuBiologics Latest Developments

12.13 Panacea Biotec Ltd

12.13.1 Panacea Biotec Ltd Company Information

12.13.2 Panacea Biotec Ltd Vaccines Administered Orally Product Offered

12.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Panacea Biotec Ltd Main Business Overview

12.13.5 Panacea Biotec Ltd Latest Developments

12.14 Bio-Med

12.14.1 Bio-Med Company Information

12.14.2 Bio-Med Vaccines Administered Orally Product Offered

12.14.3 Bio-Med Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Bio-Med Main Business Overview

12.14.5 Bio-Med Latest Developments

12.15 Halfkin Bio-Pharmaceuticals

12.15.1 Halfkin Bio-Pharmaceuticals Company Information

12.15.2 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offered

12.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview

12.15.5 Halfkin Bio-Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

Table 1. Vaccines Administered Orally Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Human

Table 3. Major Players of Animal

Table 4. Global Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 5. Global Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 6. Global Vaccines Administered Orally Revenue by Type (2016-2021) & ($ million)

Table 7. Global Vaccines Administered Orally Revenue Market Share by Type (2016-2021)

Table 8. Global Vaccines Administered Orally Sale Price by Type (2016-2021)

Table 9. Global Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 10. Global Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 11. Global Vaccines Administered Orally Value by Application (2016-2021)

Table 12. Global Vaccines Administered Orally Revenue Market Share by Application (2016-2021)

Table 13. Global Vaccines Administered Orally Sale Price by Application (2016-2021)

Table 14. Global Vaccines Administered Orally Sales by Company (2019-2021) & (K Units)

Table 15. Global Vaccines Administered Orally Sales Market Share by Company (2019-2021)

Table 16. Global Vaccines Administered Orally Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Vaccines Administered Orally Revenue Market Share by Company (2019-2021)

Table 18. Global Vaccines Administered Orally Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Vaccines Administered Orally Producing Area Distribution and Sales Area

Table 20. Players Vaccines Administered Orally Products Offered

Table 21. Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Vaccines Administered Orally Sales by Region (2016-2021) (K Units)

Table 25. Global Vaccines Administered Orally Sales Market Share by Region (2016-2021)

Table 26. Global Vaccines Administered Orally Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Vaccines Administered Orally Revenue Market Share by Region (2016-2021)

Table 28. Americas Vaccines Administered Orally Sales by Country (2016-2021) & (K Units)

Table 29. Americas Vaccines Administered Orally Sales Market Share by Country (2016-2021)

Table 30. Americas Vaccines Administered Orally Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Vaccines Administered Orally Revenue Market Share by Country (2016-2021)

Table 32. Americas Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 33. Americas Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 34. Americas Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 35. Americas Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 36. APAC Vaccines Administered Orally Sales by Region (2016-2021) & (K Units)

Table 37. APAC Vaccines Administered Orally Sales Market Share by Region (2016-2021)

Table 38. APAC Vaccines Administered Orally Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Vaccines Administered Orally Revenue Market Share by Region (2016-2021)

Table 40. APAC Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 41. APAC Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 42. APAC Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 43. APAC Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 44. Europe Vaccines Administered Orally Sales by Country (2016-2021) & (K Units)

Table 45. Europe Vaccines Administered Orally Sales Market Share by Country (2016-2021)

Table 46. Europe Vaccines Administered Orally Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Vaccines Administered Orally Revenue Market Share by Country (2016-2021)

Table 48. Europe Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 49. Europe Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 50. Europe Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 51. Europe Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Vaccines Administered Orally Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Vaccines Administered Orally Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Vaccines Administered Orally

Table 61. Key Application and Potential Industries of Vaccines Administered Orally

Table 62. Key Challenges of Vaccines Administered Orally

Table 63. Key Trends of Vaccines Administered Orally

Table 64. Vaccines Administered Orally Distributors List

Table 65. Vaccines Administered Orally Customer List

Table 66. Global Vaccines Administered Orally Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Vaccines Administered Orally Consumption Market Forecast by Region

Table 68. Global Vaccines Administered Orally Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Vaccines Administered Orally Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Vaccines Administered Orally Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Vaccines Administered Orally Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Vaccines Administered Orally Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Vaccines Administered Orally Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Vaccines Administered Orally Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Vaccines Administered Orally Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Vaccines Administered Orally Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Vaccines Administered Orally Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Vaccines Administered Orally Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Vaccines Administered Orally Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Vaccines Administered Orally Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Vaccines Administered Orally Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Vaccines Administered Orally Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Vaccines Administered Orally Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Vaccines Administered Orally Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Vaccines Administered Orally Revenue Market Share Forecast by Application (2021-2026)

Table 86. Merck Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 87. Merck Vaccines Administered Orally Product Offered

Table 88. Merck Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Merck Main Business

Table 90. Merck Latest Developments

Table 91. GSK Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 92. GSK Vaccines Administered Orally Product Offered

Table 93. GSK Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. GSK Main Business

Table 95. GSK Latest Developments

Table 96. Sanofi Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 97. Sanofi Vaccines Administered Orally Product Offered

Table 98. Sanofi Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. Sanofi Main Business

Table 100. Sanofi Latest Developments

Table 101. Lanzhou Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 102. Lanzhou Institute Vaccines Administered Orally Product Offered

Table 103. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. Lanzhou Institute Main Business

Table 105. Lanzhou Institute Latest Developments

Table 106. Serum Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 107. Serum Institute Vaccines Administered Orally Product Offered

Table 108. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. Serum Institute Main Business

Table 110. Serum Institute Latest Developments

Table 111. Valneva Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 112. Valneva Vaccines Administered Orally Product Offered

Table 113. Valneva Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 114. Valneva Main Business

Table 115. Valneva Latest Developments

Table 116. Shanghai United Cell Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 117. Shanghai United Cell Vaccines Administered Orally Product Offered

Table 118. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 119. Shanghai United Cell Main Business

Table 120. Shanghai United Cell Latest Developments

Table 121. Bibcol Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 122. Bibcol Vaccines Administered Orally Product Offered

Table 123. Bibcol Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 124. Bibcol Main Business

Table 125. Bibcol Latest Developments

Table 126. PaxVax Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 127. PaxVax Vaccines Administered Orally Product Offered

Table 128. PaxVax Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 129. PaxVax Main Business

Table 130. PaxVax Latest Developments

Table 131. Vabiotech Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 132. Vabiotech Vaccines Administered Orally Product Offered

Table 133. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 134. Vabiotech Main Business

Table 135. Vabiotech Latest Developments

Table 136. Tiantan Biological Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 137. Tiantan Biological Vaccines Administered Orally Product Offered

Table 138. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 139. Tiantan Biological Main Business

Table 140. Tiantan Biological Latest Developments

Table 141. EuBiologics Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 142. EuBiologics Vaccines Administered Orally Product Offered

Table 143. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 144. EuBiologics Main Business

Table 145. EuBiologics Latest Developments

Table 146. Panacea Biotec Ltd Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 147. Panacea Biotec Ltd Vaccines Administered Orally Product Offered

Table 148. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 149. Panacea Biotec Ltd Main Business

Table 150. Panacea Biotec Ltd Latest Developments

Table 151. Bio-Med Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 152. Bio-Med Vaccines Administered Orally Product Offered

Table 153. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 154. Bio-Med Main Business

Table 155. Bio-Med Latest Developments

Table 156. Halfkin Bio-Pharmaceuticals Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 157. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offered

Table 158. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 159. Halfkin Bio-Pharmaceuticals Main Business

Table 160. Halfkin Bio-Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Vaccines Administered Orally

Figure 2. Vaccines Administered Orally Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccines Administered Orally Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Vaccines Administered Orally Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Vaccines Administered Orally Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Human

Figure 10. Product Picture of Animal

Figure 11. Global Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 12. Global Vaccines Administered Orally Revenue Market Share by Type (2016-2021)

Figure 13. Vaccines Administered Orally Consumed in Public

Figure 14. Global Vaccines Administered Orally Market: Public (2016-2021) & (K Units)

Figure 15. Vaccines Administered Orally Consumed in Private

Figure 16. Global Vaccines Administered Orally Market: Private (2016-2021) & (K Units)

Figure 17. Global Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Figure 18. Global Vaccines Administered Orally Revenue Market Share by Application in 2020

Figure 19. Vaccines Administered Orally Revenue Market by Company in 2020 ($ Million)

Figure 20. Global Vaccines Administered Orally Revenue Market Share by Company in 2020

Figure 21. Global Vaccines Administered Orally Sales Market Share by Regions (2016-2021)

Figure 22. Global Vaccines Administered Orally Revenue Market Share by Region in 2020

Figure 23. Americas Vaccines Administered Orally Sales 2016-2021 (K Units)

Figure 24. Americas Vaccines Administered Orally Revenue 2016-2021 ($ Millions)

Figure 25. APAC Vaccines Administered Orally Sales 2016-2021 (K Units)

Figure 26. APAC Vaccines Administered Orally Revenue 2016-2021 ($ Millions)

Figure 27. Europe Vaccines Administered Orally Sales 2016-2021 (K Units)

Figure 28. Europe Vaccines Administered Orally Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa Vaccines Administered Orally Sales 2016-2021 (K Units)

Figure 30. Middle East & Africa Vaccines Administered Orally Revenue 2016-2021 ($ Millions)

Figure 31. Americas Vaccines Administered Orally Sales Market Share by Country in 2020

Figure 32. Americas Vaccines Administered Orally Revenue Market Share by Country in 2020

Figure 33. Americas Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 34. Americas Vaccines Administered Orally Sales Market Share by Application in 2020

Figure 35. United States Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC Vaccines Administered Orally Sales Market Share by Region in 2020

Figure 40. APAC Vaccines Administered Orally Revenue Market Share by Regions in 2020

Figure 41. APAC Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 42. APAC Vaccines Administered Orally Sales Market Share by Application in 2020

Figure 43. China Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 47. India Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe Vaccines Administered Orally Sales Market Share by Country in 2020

Figure 50. Europe Vaccines Administered Orally Revenue Market Share by Country in 2020

Figure 51. Europe Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 52. Europe Vaccines Administered Orally Sales Market Share by Application in 2020

Figure 53. Germany Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 54. France Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country in 2020

Figure 59. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 61. Middle East & Africa Vaccines Administered Orally Sales Market Share by Application in 2020

Figure 62. Egypt Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles